AbbVie has announced that it will be expanding its immunology pipeline by acquiring Nimble Therapeutics for $200m. The deal ...

AI is shooting for the moon and the stars but the real benefits come from anchoring it to the human voice Research conducted ...

Technology’s ability to accelerate the pace of innovation while reducing the cost is changing the dynamic of the struggle ...

Merck & Co – known as MSD outside the US and Canada – will be gaining exclusive global rights to Hansoh Pharma’s preclinical ...

Since the Orphan Drug Act was passed in 1983, pharmaceutical companies have increasingly focused on developing treatments for ...

At first glance, translating clinical outcome assessments (COAs) from their original language (most commonly English) to ...

At its heart, it comes back to being able to convey empathy – ‘the ability to understand and imagine the feelings, ...

The US Food and Drug Administration (FDA) has approved Organon’s Vtama (tapinarof) cream, 1% to treat atopic dermatitis in ...

The European Medicines Agency’s human medicines committee has recommended Galderma’s nemolizumab to treat atopic dermatitis ...

The results come two months after Merck shared positive results from the phase 3 KEYNOTE-689 trial of Keytruda as a ...

In theory, the principles of omnichannel – personalised content through the right channels to maximise customer experience – ...

Our commitments as a company Ipsen’s commitment focuses on three key areas that aim to improve the UK’s standing as a life ...